An NDRI, short for norepinephrine-dopamine reuptake inhibitor, is a type of medication that works by increasing levels of two chemical messengers in the brain: norepinephrine and dopamine. The most widely prescribed NDRI is bupropion, sold under the brand name Wellbutrin, which was first approved by the FDA in 1985 to treat major depressive disorder. NDRIs stand apart from other antidepressants because they don’t affect serotonin, the brain chemical targeted by more commonly prescribed options like Prozac or Zoloft.
How NDRIs Work in the Brain
Your brain cells communicate by releasing chemical messengers called neurotransmitters into the tiny gaps between them. Once a message is delivered, the sending cell normally reabsorbs those chemicals through specialized docking ports called transporters. This recycling process is called “reuptake.” An NDRI blocks the transporters for two specific neurotransmitters, norepinephrine and dopamine, so more of each stays available in the gap between cells for a longer period.
Norepinephrine plays a key role in alertness, focus, and energy. Dopamine is closely tied to motivation, reward, and the ability to feel pleasure. In people with depression, levels of one or both of these chemicals can be too low, contributing to fatigue, difficulty concentrating, and a flattened sense of enjoyment. By keeping more norepinephrine and dopamine active, NDRIs help restore those functions. Studies in humans confirm that bupropion increases dopamine and norepinephrine concentrations in the brain at standard clinical doses, with slightly stronger activity at the dopamine transporter than the norepinephrine transporter.
Importantly, NDRIs don’t affect serotonin or bind to other neurotransmitter receptors. This narrow focus is what gives them a distinct side effect profile compared to other antidepressants.
Common NDRI Medications
The NDRI class includes a small number of medications:
- Bupropion (Wellbutrin) is the primary NDRI prescribed for depression, seasonal affective disorder, and smoking cessation (marketed as Zyban for that purpose). It comes in immediate-release, sustained-release, and extended-release formulations.
- Methylphenidate (Ritalin, Concerta) is used primarily for ADHD. While it shares the same basic mechanism of blocking norepinephrine and dopamine reuptake, it’s classified as a stimulant and is typically discussed in the context of attention disorders rather than depression.
- Dexmethylphenidate (Focalin) is a refined version of methylphenidate, also used for ADHD.
When most people hear “NDRI” in the context of depression or mental health treatment, they’re usually talking about bupropion specifically, since it’s the only one in this class that’s FDA-approved as an antidepressant.
What NDRIs Are Prescribed For
Bupropion has two FDA-approved uses: treating major depressive disorder (including seasonal affective disorder) and helping adults quit smoking. Its dopamine-boosting properties make it particularly useful for people whose depression shows up as low energy, poor motivation, or an inability to enjoy things they used to care about.
Beyond those official approvals, bupropion has been used off-label for ADHD in both adults and children, as well as for sexual dysfunction, weight management, and substance use disorders. GlaxoSmithKline was fined over $757 million for promoting some of these unapproved uses in the early 2000s, though many clinicians still prescribe bupropion off-label based on their clinical judgment. There is also limited and still-debated evidence for its use in bipolar disorder.
How NDRIs Differ From SSRIs
The most commonly prescribed antidepressants are SSRIs (selective serotonin reuptake inhibitors), which include drugs like fluoxetine (Prozac), sertraline (Zoloft), and escitalopram (Lexapro). SSRIs work on serotonin. NDRIs work on dopamine and norepinephrine. That fundamental difference creates meaningful distinctions in how each class feels to take.
The biggest practical difference involves sexual side effects. SSRIs are well known for causing problems with libido, arousal, and orgasm, and in some cases these effects can persist even after stopping the medication. NDRIs carry a significantly lower risk of sexual dysfunction because they don’t interact with the serotonin system. This is one of the most common reasons a prescriber might choose bupropion over an SSRI, or add it alongside one.
Weight is another area where the two classes diverge. SSRIs are often associated with weight gain over time. Bupropion is considered weight-neutral or may even be associated with modest weight loss, which is part of why it’s sometimes used off-label for weight management.
Side Effects and Risks
Because NDRIs increase norepinephrine and dopamine, two chemicals that ramp up the body’s “alert” systems, their side effects tend to lean toward overstimulation rather than the sluggishness some people experience with SSRIs. The most commonly reported effects include insomnia, anxiety, agitation, and restlessness. Some people also experience dry mouth, headache, or nausea, particularly when starting the medication.
The most serious risk associated with bupropion is seizures. The risk is dose-dependent, meaning it increases at higher doses. For this reason, bupropion is contraindicated in people with eating disorders, specifically anorexia nervosa and bulimia nervosa, because the electrolyte imbalances and nutritional disruptions common in those conditions already lower the seizure threshold. People with a history of seizure disorders are also generally advised against taking it.
What to Expect When Starting an NDRI
For depression, bupropion is typically started at a low dose and gradually increased. The extended-release version (Wellbutrin XL) usually begins at 150 mg once daily in the morning, with a typical maximum of 300 mg per day. The sustained-release version is taken twice daily, at least 8 hours apart, with a usual maximum of 400 mg per day. Morning dosing is standard because the activating effects of the drug can interfere with sleep if taken later in the day.
Like most antidepressants, bupropion doesn’t work immediately. Most people begin to notice changes in energy and motivation within the first one to two weeks, but the full antidepressant effect generally takes four to six weeks to develop. The stimulant NDRIs used for ADHD, like methylphenidate, work much faster, often within 30 to 60 minutes of taking a dose.
If you’re comparing NDRIs to other antidepressant options, the key distinction is their energizing, dopamine-focused profile. They tend to work best for people who experience depression as fatigue, low drive, and emotional numbness rather than primarily as anxiety or agitation. For people who already feel overstimulated or have trouble sleeping, the activating nature of an NDRI may not be the best fit.